(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THYBETAXOR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THYBETAXOR

ST13

US500000079409214

Class

5

Filing

79409214

Registration

8054740

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

07/09/2026

Trademark type

Word

Nice classes

5

Filing date

10/11/2024

Registration date

12/09/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/09/2025

Last transaction

07/09/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

CN

Examiner

MESSICK, TABITHA LEE

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Cascade Pharmaceuticals, Inc

Representatives

Eric Lamb Frost Brown Todd LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposes for the treatment of inflammatorymetabolicimmune system related diseases and disorders; diagnostic preparations for medical purposes; drugs for medical purposespharmaceutical drug preparations for the prevention and treatment of inflammatorymetabolicimmune system related diseases and disorders; bacteriological preparations for medical and veterinary use; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; chemical preparations for medical purposesbeing pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune systemdigestive systemmetabolic system; opotherapy preparations; biological preparations for medical purposesbeing pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune systemdigestive systemmetabolic system; medicine casesportablefilled in the nature of containers for medical use sold filled with a platelet additive solution; stem cells for medical purposes; chemical reagents for medical or veterinary purposes;

Publications

History of USPTO decisions and trademark events.

30 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/09/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

06/25/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/21/2026

FIMP

FINAL DISPOSITION PROCESSED

06/21/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/30/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/13/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/13/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/09/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/09/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/09/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/21/2025

PUBO

PUBLISHED FOR OPPOSITION

10/21/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/15/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/19/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/22/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/22/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/22/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/25/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/25/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/25/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/25/2025

RFNT

REFUSAL PROCESSED BY IB

06/27/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/09/2025

RFRR

REFUSAL PROCESSED BY MPU

06/09/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/06/2025

CNRT

NON-FINAL ACTION WRITTEN

04/05/2025

DOCK

ASSIGNED TO EXAMINER

03/21/2025

MAFR

APPLICATION FILING RECEIPT MAILED

11/15/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/15/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/14/2024

Continuous trademark protection

Get notified about every new filing that threatens THYBETAXOR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.